Recce Pharmaceuticals Ltd (ASX: RCE) is pioneering the development and commercialisation of a new class of synthetic antibiotics with broad spectrum activity designed to address the urgent global health problem of antibiotic resistant superbugs.
Ani Pharmaceuticals
2 followers
Xenco Medical
1 follower
Bristol-Myers Squibb
319 followers
Astellas Pharma
63 followers
Viatris
54 followers
NYU Langone Health
51 followers
Alnylam Pharmaceuticals
50 followers
Syneos Health
38 followers
Catalent
35 followers
Organon
29 followers
Parexel
21 followers
Otsuka Group
22 followers